The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Stem Cell Collection and Gene Transfer in Fanconi Anemia
Open accessAbstract
Fanconi anemia (FA) is a rare genetic syndrome characterized by progressive bone marrow failure (BMF), congenital anomalies, and a predisposition to malignancy. Successful gene transfer into hematopoietic stem cells (HSCs) could reverse BMF in this disease. We developed clinical trials to determine whether a sufficient number of CD34(+) stem cells could be collected for gene modification and to evaluate the safety and efficacy of HSC-corrective gene transfer in FA genotype A (FANCA) patients. Here, we report that FA patients have significant depletion of their BM CD34(+) cell compartment even before severe pancytopenia is present. However, oncoretroviral-mediated ex vivo gene transfer was efficient in clinical scale in FA-A cells, leading to reversal of the cellular phenotype in a significant percentage of CD34(+) cells. Re-infusion of gene-corrected products in two patients was safe and well tolerated and accompanied by transient improvements in hemoglobin and platelet counts. Gene correction was transient, likely owing to the low dose of gene-corrected cells infused. Our early experience shows that stem cell collection is well tolerated in FA patients and suggests that collection be considered as early as possible in patients who are potential candidates for future gene transfer trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The success of gene therapy approaches to FA in a clinical setting has been limited by a combination of factors, including the paucity of autologous CD34+ cells available as targets for gene correction, reservations about the use of cytoreductive therapy to “make space” for the autologous graft, and potentially defective engraftment of FA HSC following prolonged in vitro processing[33–35].”
From Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia (2009) · cites this paper as [35]
In the citing paper
“Despite considerable challenges related to the procurement of autologous CD34+ HSC/P, two clinical gene therapy trials involving a total of 7 patients with FANCA and FANCC mutations have been conducted and these studies established the feasibility of gammaretroviral gene transfer of FA genes into human hematopoietic progenitor cells[34,35].”
From Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia (2009) · cites this paper as [35]
In the citing paper
“In addition, the predicted selective advantage of genetically corrected HSC over FANC-deficient HSC has not been observed in either trial.”
From Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia (2009) · cites this paper as [35]
In the citing paper
“However, broad inter-individual variability of efficacy exists in normal healthy subjects, patients pre-treated with chemotherapy, and patients with Fanconi anemia[34,35,69,81].”
From Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia (2009) · cites this paper as [35]
In the citing paper
“Thus, the target CD34+ cell dose of 2×106 per kg future weight was not obtained in any patient.”
From Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia (2009) · cites this paper as [35]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
Sutherland, D. R., Anderson, L., Keeney, M., Nayar, R., & Chin-Yee, I. H. (1996) · Journal of Hematotherapy · doi:10.1089/scd.1.1996.5.213 · Cited by 1,277
Ott, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
Self-citationCorrection of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 975
Broxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041385 · Cited by 970
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
Liles, W. C., Broxmeyer, H. E., Rodger, E., Wood, B. L., Hübel, K., Cooper, S. H., Hangoc, G., Bridger, G. J., Henson, G. W., Calandra, G., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0663 · Cited by 718
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
Miller, A. D., Garcia, J. V., von Suhr, N., Lynch, C. M., Wilson, C. A., & Eiden, M. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2220-2224.1991 · Cited by 627
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2170 · Cited by 618
Self-citationThe Fanconi Anemia/BRCA pathway: new faces in the crowdPreprint
Kennedy, R. D., & D’Andrea, A. D. (2005) · Genes & Development · doi:10.1101/gad.1370505 · Cited by 474
Modulation of hematopoietic stem cell homing and engraftment by CD26
Christopherson, K. W., Hangoc, G., Mantel, C. R., & Broxmeyer, H. E. (2004) · Science · doi:10.1126/science.1097071 · Cited by 452
Cited by
Items 101–180 of 180
Chatla, S., Du, W., Wilson, A. F., Meetei, A. R., & Pang, Q. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101550 · Cited by 15
Oncolytic vaccinia virus: a silver bullet?
Lusky, M., Erbs, P., Foloppe, J., & Acres, R. B. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.137 · Cited by 14
Saha, A., Palchaudhuri, R., Lanieri, L., Hyzy, S. L., Riddle, M. J., Panthera, J., Eide, C. R., Tolar, J., Panoskaltsis‐Mortari, A., Gorfinkel, L., et al. (2024) · Blood · doi:10.1182/blood.2023023549 · Cited by 13
Shi, L., Han, Z., Li, X., Li, M., Han, H., Chen, J., & Zang, S. (2014) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1704 · Cited by 13
Verhoeyen, E., Relouzat, F., Cambot, M., Costa, C., Négre, D., Legrand, F., Joubert, C., Grand, R. L., Cosset, F., Leboulch, P., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.020 · Cited by 13
Dinsart, C., Pervolaraki, K., Stroh-Dege, A., Lavie, M., Ronsse, I., Rommelaere, J., Damme, J. V., Raemdonck, K. V., & Struyf, S. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.108 · Cited by 12
Fernández-García, M., Lamana, M. L., Hernando-Rodríguez, M., Sánchez‐Domínguez, R., Bueren, J. A., & Yañez, R. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.076 · Cited by 11
Kovuru, N., Mochizuki‐Kashio, M., Menna, T. N., Jeffrey, G., Hong, Y., Yoon, Y. M., Zhang, Z., & Kurre, P. (2024) · Nature Communications · doi:10.1038/s41467-024-46159-1 · Cited by 11
Development of targeted oncolytic virotherapeutics through translational research
Liu, T., Hwang, T.-H., Bell, J. C., & Kirn, D. H. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.9.1381 · Cited by 11
Progress of oncolytic viruses in sarcomas
Lettieri, C. K., Hingorani, P., & Kolb, E. A. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.205 · Cited by 11
Dix ans de thérapie génique Réflexions
Cavazzana, M., Hacein‐Bey‐Abina, S., & Fischer, A. (2010) · médecine/sciences · doi:10.1051/medsci/2010262115 · Cited by 11
Adair, J. E., Zhao, X., Chien, S. S., Fang, M., Wohlfahrt, M. E., Trobridge, G. D., Taylor, J. A., Beard, B. C., Kiem, H., & Becker, P. S. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0905-0 · Cited by 10
The impact of clonal diversity and mosaicism on haematopoietic function in Fanconi anaemia
Hughes, A. D., & Kurre, P. (2021) · British Journal of Haematology · doi:10.1111/bjh.17653 · Cited by 10
Stem Cell Therapy for Fanconi Anemia
Zhang, Q. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_67 · Cited by 10
Hematopoietic development: a gap in our understanding of inherited bone marrow failure
Kurre, P. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.12.003 · Cited by 10
Zaibak, F., Kozlovski, J., Vadolas, J., Sarsero, J. P., Williamson, R., & Howden, S. E. (2009) · Gene Therapy · doi:10.1038/gt.2008.187 · Cited by 10
Correction of Fanconi Anemia Group C Hematopoietic Stem Cells Following Intrafemoral Gene Transfer
Habi, O., Girard, J., Bourdages, V., Delisle, M., & Carreau, M. (2010) · Anemia · doi:10.1155/2010/947816 · Cited by 10
Ethics of Cancer Gene Transfer Clinical Research
Kimmelman, J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2727-2_15 · Cited by 9
Diana, J., Manceau, S., Leblanc, T. M., Magnani, A., Magrin, E., Bendavid, M., Couzin, C., Joseph, L., Soulier, J., Cavazzana, M., et al. (2021) · Transfusion · doi:10.1111/trf.16721 · Cited by 9
The PI3K/Akt1 pathway enhances steady-state levels of FANCL
Dao, K.-H. T., Rotelli, M. D., Brown, B. R., Yates, J. E., Rantala, J., Tognon, C. E., Tyner, J. W., Druker, B. J., & Bagby, G. C. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-03-0144 · Cited by 9
FANCD2 Alleviates Physiologic Replication Stress in Fetal Liver HSCPreprint
Mochizuki‐Kashio, M., Yoon, Y. M., Menna, T. N., Grompe, M., & Kurre, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.30.320796 · Cited by 9
Hudda, Z., & Myers, K. C. (2023) · Hematology · doi:10.1182/hematology.2023000471 · Cited by 8
Why hematopoietic stem cells fail in Fanconi anemia: Mechanisms and models
Liu, S., Vivona, E., & Kurre, P. (2024) · BioEssays · doi:10.1002/bies.202400191 · Cited by 8
On how Rac controls hematopoietic stem cell activity
Cancelas, J. A. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03378.x · Cited by 6
Self-citationVerhagen-Oldenampsen, J., Haanstra, J. R., van Strien, P. M. H., Valkhof, M. G., Touw, I. P., & Lindern, M. V. (2012) · Anemia · doi:10.1155/2012/783068 · Cited by 8
Zha, J., Kunselman, L., Xie, H. M., Ennis, B., Shah, Y., Qin, X., Fan, J., Babushok, D. V., & Olson, T. S. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004640 · Cited by 8
Anticancer Gene Transfer for Cancer Gene Therapy
Pazarentzos, E., & Mazarakis, N. D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4471-6458-6_13 · Cited by 7
TALEN mediated gene editing in a mouse model of Fanconi anemia
Pino-Barrio, M. J., Gimenez, Y. A., Villanueva, M., Hildenbeutel, M., Sánchez‐Domínguez, R., Rodríguez, S., Pujol, R. M., Surrallés, J., Río, P., Cathomen, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63971-z · Cited by 7
Antiglioma Oncolytic Virotherapy: Unattainable Goal or a Success Story in the Making?
Dey, M., Auffinger, B., Lesniak, M. S., & Ahmed, A. U. (2013) · Future Virology · doi:10.2217/fvl.13.47 · Cited by 7
Possible Applications for Replicating Hiv-1 Vectors
Das, A. T., Jeeninga, R. E., & Berkhout, B. (2010) · HIV Therapy · doi:10.2217/hiv.10.20 · Cited by 7
Ethics of Cancer Gene Transfer Clinical Research
Kimmelman, J. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-561-9_23 · Cited by 7
Employing Live Microbes for Vaccine Delivery
Loessner, H., Schwantes, A., Hamdorf, M., Komor, U., Leschner, S., & Weiß, S. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0709-6_5 · Cited by 6
Release Testing of Retroviral Vectors and Gene-Modified Cells
Nordling, D., Kaiser, A., & Reeves, L. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-409-4_18 · Cited by 6
Self-citationA Possible Approach for Stem Cell Gene Therapy of Fanconi Anemia
Song, L. (2009) · Current Gene Therapy · doi:10.2174/156652309787354667 · Cited by 5
Long, J. D., Trope, E. C., Yang, J., Rector, K., & Kuo, C. Y. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.03.011 · Cited by 4
Virotherapy of digestive tumors with rodentparvovirus: overview and perspectives
Akladios, C. Y., & Aprahamian, M. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1151492 · Cited by 4
Precise somatic genome editing for treatment of inborn errors of immunity
Meng, Q., Sun, H., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960348 · Cited by 4
A small molecule p53 activator attenuates Fanconi anemia leukemic stem cell proliferation
Du, W., Li, X., Wilson, A. F., & Pang, Q. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0882-5 · Cited by 4
Correcting the aberrant Fanconi anemia transcriptional program by gene therapy
Dror, Y. (2023) · Haematologica · doi:10.3324/haematol.2023.283031 · Cited by 4
BioKnife, a Modified Sendai Virus, to Resect Malignant Tumors
Yonemitsu, Y., Ueda, Y., & Hasegawa, M. (2013) · Springer eBooks · doi:10.1007/978-4-431-54556-9_6 · Cited by 3
The emergence of a unified mechanism in the Fanconi anemia pathway
Xu, X., Guo, R., & Xu, D. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00053-y · Cited by 3
McLeman, L., Glaser, A., Conyers, R. K., & Deans, A. J. (2023) · Frontiers in Hematology · doi:10.3389/frhem.2023.1216596 · Cited by 3
Recent Advances in Hematopoietic Stem Cell Gene Therapy
Tsuruta, T. (2013) · InTech eBooks · doi:10.5772/53587 · Cited by 3
Choo, S.-A. S., Tong, A. H., Fields, E., Mack, H. M., Humbert, O., Radtke, S., & Kiem, H. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101528 · Cited by 2
Self-citationCurrent Status and Developments in Gene Therapy for Thalassemia and Sickle Cell Disease
Yannaki, E., & Karponi, G. (2014) · Thalassemia Reports · doi:10.4081/thal.2014.4876 · Cited by 2
Verghese, S. C., Goloviznina, N. A., & Kurre, P. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0431-z · Cited by 2
Perspectives on gene therapy for Fanconi anemia
Navarro, S., Río, P., & Bueren, J. A. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1062752 · Cited by 2
Fanconi Anemia: A Pathway of Hematopoiesis and Cancer Predisposition
Suliman, A. Y., Smith, F. O., & Kupfer, G. M. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_4 · Cited by 2
Self-citationMusings on genome medicine: gene therapy
Nathan, D. G., & Orkin, S. H. (2009) · Genome Medicine · doi:10.1186/gm38 · Cited by 2
Why, What and How Can We Learn from a Rare Disease Like Fanconi Anemia?
Schroeder-Kurth, T. M. (2007) · KARGER eBooks · doi:10.1159/000102542 · Cited by 1
From the Molecular Biology to the Gene Therapy of a DNA Repair Syndrome: Fanconi Anemia
Río, P., Navarro, S., & Juan, A. D. (2011) · InTech eBooks · doi:10.5772/24657 · Cited by 1
Oncolytic Adenovirus Research And Applications
Kangasniemi, L., & Hemminki, A. (2010) · Future Virology · doi:10.2217/fvl.10.59 · Cited by 1
Genetic Correction of Hematopoiesis in Fanconi Anemia: The Case for a Non-HSC-Autonomous Defect
Skinner, A. M., & Kurre, P. (2009) · Molecular Therapy · doi:10.1038/mt.2009.138 · Cited by 1
Скоробогатова, Е. В., Киргизов, К. И., Balashov, D., Trakhtman, P., Skvortsova, Y. V., Пристанскова, Е. А., Novichkova, G. A., Мaschan, M. A., Maschan, A., & Rumyantsev, A. G. (2016) · Russian Journal of Pediatric Hematology and Oncology · doi:10.17650/2311-1267-2016-3-1-23-34 · Cited by 1
Les virus oncolytiques, première validation pour une classe thérapeutique pas si nouvelle
Gougis, P., & Teixeira, L. (2016) · ONCOLOGIE · doi:10.1007/s10269-016-2660-2 · Cited by 1
Haworth, K. G., Ironside, C. M., Ramirez, M. A., Weitz, S., Beard, B. C., Schwartz, J. D., Adair, J. E., & Kiem, H. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3050 · Cited by 1
Hematopoietic Cell Transplantation for the Treatment of Patients with Bone Marrow Failure Syndromes
Dietz, A. C., & Pulsipher, M. A. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_9 · Cited by 1
Terapias avanzadas en enfermedades raras
Fillat, C., Río, M. D., Martínez‐Santamaría, L., & Bueren, J. A. (2018) · Arbor · doi:10.3989/arbor.2018.789n3009 · Cited by 1
Heritable predisposition to childhood hematologic malignancies
Seif, A. E., Lange, B. J., Biegel, J. A., & Nichols, K. E. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.012 · Cited by 1
Lundstrom, K. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00049-4 · Cited by 1
Mechanisms of Action of Low-Dose Metronomic Chemotherapy
Fremder, E., & Shaked, Y. (2014) · Springer eBooks · doi:10.1007/978-3-662-43604-2_2 · Cited by 1
Williams, D. A. (2009) · Molecular Therapy · doi:10.1038/mt.2009.57 · Cited by 1
Self-citationGenetic Manipulation of Hematopoietic Stem Cells
Adair, J. E., Trobridge, G. D., & Kiem, H. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch8 · Cited by 1
Genetic Manipulation of Hematopoietic Stem Cells
Trobridge, G. D., & Kiem, H. (2009) · Wiley eBooks · doi:10.1002/9781444303537.ch10
Xing, W., Xu, M., & Yang, F. (2013) · InTech eBooks · doi:10.5772/52729
The Development of Targeted Cancer Gene-Therapy Adenoviruses for High-Grade Glioma Treatment
Post, D. E., & Meir, E. G. V. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_47
Verhagen-Oldenampsen, J. (2013) · EUR Research Repository (Erasmus University Rotterdam)
Response: Homing defect in hematopoietic cells from Fanconi anemia patients
Zhang, X., & Pang, Q. (2009) · Blood · doi:10.1182/blood-2009-01-198077
Measles Virotherapy in Prostate Cancer Treatment: a Novel Antitumor Approach
Msaouel, P., & Galanis, E. (2009) · Future Virology · doi:10.2217/fvl.09.9
The PI3K/Akt1 pathway enhances steady state levels of FANCL
Dao, K., Rotelli, M. D., Brown, B. R., Yates, J. E., Rantala, J., Tognon, C. E., Tyner, J. W., Druker, B. J., & Bagby, G. C. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.05.165
Viral biotechnology: Production perspective
Waqar, K., Ullah, H., & Gul, A. (2016) · CRC Press eBooks · doi:10.1201/b19543-23
Gracia Quejereta: Una madrileña en Oxford
Rioyo, J. (1996) · Cinemanía
Ignatova, Z., Zimmermann, K.-H., & Martínez-Pérez, I. (2008) · Springer eBooks · doi:10.1007/978-0-387-73637-2_3
Gene Therapy for Nonneoplastic Hematologic and Histiocytic Disorders
Washington, K. N., Tisdale, J. F., & Hsieh, M. M. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_45
DEALING WITH THE MAIN CHALLENGES OF FANCONI ANEMIA MOLECULAR DIAGNOSIS AND THERAPY
Persico, I. (2023) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
和寛, 野., & Kazuhiro, N. (2023) · Institutional Repositories DataBase (IRDB)
Origine embryonnaire des manifestations hématologiques de l'Anémie de Fanconi
Domenech, C. (2017) · theses.fr (ABES) · doi:10.70675/f824d508zebfdz409cz90a3z63f5bba92601
Oppezzo, A. (2021) · theses.fr (ABES) · doi:10.70675/53736911zeb54z418czb336z493f788bd19f
Gene-targeted therapies in inherited bone marrow failure syndromes
Cipolli, M., & Bezzerri, V. (2026) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.09.012
Metadata
- Authors
- Kelly, P. F., Radtke, S., Kalle, C. V., Balcik, B., Bohn, K., Mueller, R., Schuesler, T., Haren, M., Reeves, L., Cancelas, J. A., Leemhuis, T., Harris, R., Auerbach, A. D., Smith, F. O., Davies, S. M., & Williams, D. A.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati (US)
- Rockefeller University (US)
- Corresponding author
- Williams, David A
- ORCID
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 15
- Issue
- 1
- Pages
- 211-219
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2007940575
- Cited by
- 180
- References
- 46
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 7 · 2023: 8 · 2022: 3 · 2021: 8 · 2020: 8 · 2019: 5 · 2018: 8 · 2017: 9 · 2016: 13 · 2015: 9 · 2014: 6 · 2013: 15 · 2012: 16
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R37HL032987, R37 HL23987, R01HL081499)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- Fanconi anemia, FANCA, hematopoietic stem cells, CD34+ cell collection, ex vivo gene transfer, oncoretroviral vectors, bone marrow failure, stem cell depletion, clinical trial safety and efficacy
- MeSH terms
- Adolescent, Bone Marrow, Cell Separation, Child, Child, Preschool, Fanconi Anemia, Humans, Infant, Stem Cells, Genetic Therapy, DNA, Complementary, Antigens, CD34, Transgenes, Fanconi Anemia Complementation Group A Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
